Part 312—Investigational New Drug Application

1. CFR
2. ›
3. Title 21
4. ›
5. Chapter I
6. ›
7. Part 312

Subparts

• A
  Subpart A—General Provisions Sections 312.1–312.10
• B
  Subpart B—Investigational New Drug Application (IND) Sections 312.20–312.38
• C
  Subpart C—Administrative Actions Sections 312.40–312.48
• D
  Subpart D—Responsibilities of Sponsors and Investigators Sections 312.50–312.70
• E
  Subpart E—Drugs Intended to Treat Life-threatening and Severely-debilitating Illnesses Sections 312.80–312.88
• F
  Subpart F—Miscellaneous Sections 312.110–312.145
• G
  Subpart G—Drugs for Investigational Use in Laboratory Research Animals or In Vitro Tests Section 312.160
• H
  Subpart H [Reserved]
• I
  Subpart I—Expanded Access to Investigational Drugs for Treatment Use Sections 312.300–312.320